Regulatory and ClinicalStudy CompleteAug 20, 2026 · 9:16am ET
CELZCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Creative Medical Technology Completes Enrollment and Treatment in FDA-Cleared ADAPT Trial
The trial is moving to follow-up and Phase 3 planning.